Does RITUXIMAB Cause Progressive multifocal leukoencephalopathy? 1,647 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,647 reports of Progressive multifocal leukoencephalopathy have been filed in association with RITUXIMAB (Rituxan). This represents 0.9% of all adverse event reports for RITUXIMAB.
1,647
Reports of Progressive multifocal leukoencephalopathy with RITUXIMAB
0.9%
of all RITUXIMAB reports
685
Deaths
526
Hospitalizations
How Dangerous Is Progressive multifocal leukoencephalopathy From RITUXIMAB?
Of the 1,647 reports, 685 (41.6%) resulted in death, 526 (31.9%) required hospitalization, and 203 (12.3%) were considered life-threatening.
Is Progressive multifocal leukoencephalopathy Listed in the Official Label?
Yes, Progressive multifocal leukoencephalopathy is listed as a known adverse reaction in the official FDA drug label for RITUXIMAB.
What Other Side Effects Does RITUXIMAB Cause?
Off label use (39,751)
Drug ineffective (32,186)
Rheumatoid arthritis (19,850)
Pain (16,675)
Fatigue (15,602)
Arthralgia (12,529)
Rash (12,102)
Drug intolerance (11,876)
Infusion related reaction (11,871)
Joint swelling (11,170)
What Other Drugs Cause Progressive multifocal leukoencephalopathy?
NATALIZUMAB (1,668)
CYCLOPHOSPHAMIDE (782)
PREDNISONE (606)
PREDNISOLONE (439)
TACROLIMUS (438)
METHOTREXATE (428)
DOXORUBICIN (421)
MYCOPHENOLATE MOFETIL (414)
VINCRISTINE (376)
BENDAMUSTINE (342)
Which RITUXIMAB Alternatives Have Lower Progressive multifocal leukoencephalopathy Risk?
RITUXIMAB vs RITUXIMAB-ABBS
RITUXIMAB vs RITUXIMAB-ARRX
RITUXIMAB vs RITUXIMAB-PVVR
RITUXIMAB vs RIVAROXABAN
RITUXIMAB vs RIVASTIGMINE